Interestingly, and unexpectedly, mutations in one gene. GJB2, are responsible for half of severe-to-profound autosomal recessive non-syndrorn~c hearing loss in multiplex families from France, Brltain. Tunisla. New Zealand. and the United States. Thls findlng makes GJB2-related deafness the most common type of hereditary congenital hearing loss In these countries In approximately two-thtrds of persons wlth GJB2-related deafness, a single mutation is found, the deletion of one of six contiguous deoxyguanoslnes, referred to as the 35delG mutation. The carrier frequency for thls allele In the general population in the Midwestern Un~ted States is 2.5% (+I-0 66%) The total carrier rate for all GJB2 deafnesscausing mutations is 3 01% (range, 2 54%-3.56%) The corresponding predicted prevalence of GJB2-related congenital deafness is 22 7 (range, 15.1-31.9) per 100.000 blrths. More than Wo-thirds of these individuals have profound or severe-to-profound hearlng loss, although there can be phenotypic variability In the degree of loss even within the same family.
These data can be used to provlde lnformatlon for genetlc counseling and esbmates of recurrence nsks for hearlng couples wlth a deaf chlld The chance for a normal-hear~ng couple to have a second deaf chlld can be calculated to be 17 5% (range, 15 0%-204%) If the first deaf child undergoes genetic testing and GJ82 deafnesscauslng mutations are ~denbfied, the recurrence rlsk cllmbs to 25% In the absence of these mutabons, 11 drops to 14% As genetic testlng becomes more prevalent ~t is llkely that this lnformatlon will facllltate earlier habllltabon in a substantlal percentage of deaf Infants and ultimately may provlde parents wlth valuable prognostic and therapeutic lnformatlon Mitochondrial Deafness. N . .
Department of Pediatrics and
Medical Genetics, Cedars-Sinai Medical Center and UCLA, Los Angeles. CA Several mitochondrial mutations have been implicated in predisposing to non-syndromic and ototoxic hearing impairment. In addition acquired rnitochondrial mutations may be involved in presbycusis, the hearing loss associated with aging. While the elucidation of these mutations allows genetic counseling and prevention of a significant propotion of aminoglycoside induced ototoxicity, the intracelluhr pathophysiological events leading from the n-utations to the deafness phenotype have remained poorly understood. In addition, despite the fad that most inherited mitochondrial mutations associated with hearing impairment are homoplasmic, the clinical phenotype can generally not be predicted.
Using a genetic approach we have demonstrated that even in the simplest case of a homoplasmic rnitochondrial mutation, with minimal or no variability in mitochondrial haplotype, and minimal variability in environmental exposures, the clinical phenotype depends on several nuclear factors. To elucidate these modulating nudear genes, and in order to understand the pathophysiology of the mitochondrial deafness mutations, we use a combined genetic and candidate gene approach. The genetic approach involves systematic genome screens in families with the mitochondrial mutation and hearing impaired family members. Candidate genes are mainly sought among genes that affect mitochondrial RNA processing andlor translation. We have thus started to identify and characterize the nuclear encoded genes and proteins invoked in these processes, and screen them for cochlea speclc isoforms or splice variants.
(Xlr approach can serve as a general m d e l on how to dissect pathophysiological pathways between genetic mutations and phenotype. This wiil be necessary both for polygenic and simple Mendelian genetic diseases. The analysis of these intracellular pathways represents the challenge of genetics in the next few decades, may require new models of thinking about intracellubr interactions, and wi U be an important step in the development of therapeutic interventions and a detailed understanding of cochlea specific processes. Mitochondrial mutations with their puzzling features of incomplete penetrance and .tissue specificrty represent an excellent paradigm to anack these questions. (Supported by NlHNlDCD grants R01 DC04092. R01 DC01402 and R01 DC02273).
